DELRAY BEACH, Fla., March 29 /PRNewswire-FirstCall/ -- VeriChip Corporation (NASDAQ:CHIPNASDAQ:-NASDAQ:News), a provider of RFID systems for healthcare and patient-related needs, will present at the American Medical Directors Association (AMDA) 30th Annual Symposium in Hollywood, Florida, on March 29- 30, 2007. The conference attracts over 4000 medical directors, attending physicians, nurses, administrators, consultant pharmacists and other long-term care professionals. VeriChip expects to enroll additional physicians in its VeriMed Patient Identification System network through the symposium. Presenting on behalf of VeriChip is AMDA Foundation Chair and former AMDA President Jonathan Musher, MD, CMD.
AMDA is the professional association of medical directors and physicians practicing in the long term care continuum dedicated to excellence in patient care by providing education, advocacy, information, and professional development.
About VeriChip Corporation VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Inc. (NASDAQ: ADSXNASDAQ:-NASDAQ:News), which also owns a majority position in Digital Angel Corporation (AMEX:DOCAMEX:-AMEX:News). For more information on VeriChip, please call 1-800-970- 2447, or email . Additional information can be found online at http://www.verichipcorp.com/.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
Contact:
VeriChip Corporation
Allison Tomek
561-805-8000
The Ruth Group
Nick Laudico (investors)
(646) 536-7030
Jason Rando (media)
(646) 536-7025
DATASOURCE: VeriChip Corporation CONTACT: Allison Tomek, VeriChip Corporation, +1-561-805-8000, ; or Nick Laudico (investors), +1-646-536-7030, , or Jason Rando (media), +1-646-536-7025, , both of The Ruth Group Web site: http://www.verichipcorp.com/
|